Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy

about

Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine

P2860

Q58716650-4495CAD8-F3D7-4F63-8B2E-B608C016D3C9

P2860

Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy

Item

http://www.wikidata.org/entity/Q57039821

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy

@en

Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy

@nl

type

Item

label

Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy

@en

Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy

@nl

prefLabel

Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy

@en

Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy

@nl

P1476

Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy

@en

P2093

Dongsheng Duan

http://www.w3.org/2001/XMLSchema#string

P2860

Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy

Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufacturing for clinical studies

Safety and efficacy of gene transfer for Leber's congenital amaurosis

Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors

Manufacturing of recombinant adeno-associated viral vectors for clinical trials

Humoral immunity to AAV vectors in gene therapy: challenges and potential solutions

Marginal level dystrophin expression improves clinical outcome in a strain of dystrophin/utrophin double knockout mice

Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex

Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy

ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES

P304

2337-2356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YMTHE.2018.07.011

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30093306

http://www.w3.org/2001/XMLSchema#string

P921

P932

6171037

http://www.w3.org/2001/XMLSchema#string

Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy

about

P2860

P2860

Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932